BASI OPENS NEW OFFICE IN EUROPE TO BETTER SERVE
PHARMACEUTICAL AND BIOTECH COMPANIES
(WARWICKSHIRE, UK — November 12, 2008) — BASi <http://www.basinc.com/> , a leading provider of contract laboratory services and manufacturer of scientific instruments in the US, has announced the opening of its new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with expanded labs provides clients with enhanced capabilities throughout Europe.
Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies. BASi Europe also distributes the complete line of BASi instruments and equipment, as well as providing support for customers and distributors throughout Europe.
“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, managing director of BASi Europe. “We currently have multiple industry standard LC-MS/MS stations as well as LC-EC and other analytical technologies, and we are investing in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”
Visit with Mark Wareing, BASi Europe managing director, and other BASi representatives at the upcoming AAPS Annual Meeting and Exhibition, November 16-20, Atlanta, GA. Stop by booth #1016.
About BASi
BASi provides contract research services and specialized instrumentation and accessories for electrochemistry and in vivo sampling products to the world’s leading drug development companies. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking new drugs to market. Visit www.BASInc.com <http://www.basinc.com/> for more information about BASi.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.